Invex Therapeutics Ltd (IXC.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.13 Million AUD | 75.04% |
| 2023 | -8.54 Million AUD | -111.92% |
| 2022 | -4.03 Million AUD | -65.11% |
| 2021 | -2.44 Million AUD | 25.76% |
| 2020 | -3.29 Million AUD | -1316.62% |
| 2019 | -232.25 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -3.34 Million AUD | 60.88% |
| 2024 Q2 | -2.48 Million AUD | 0.0% |
| 2024 Q4 | 355.71 Thousand AUD | 0.0% |
| 2023 Q3 | -1.95 Million AUD | 57.96% |
| 2023 FY | -8.54 Million AUD | -111.92% |
| 2023 Q4 | -4.36 Million AUD | -123.52% |
| 2023 Q2 | -4.64 Million AUD | -100.0% |
| 2023 Q1 | -2.32 Million AUD | -5.67% |
| 2022 Q2 | -2.01 Million AUD | -100.0% |
| 2022 Q1 | -1 Million AUD | 20.67% |
| 2022 FY | -4.03 Million AUD | -65.11% |
| 2022 Q4 | -2.19 Million AUD | -118.09% |
| 2022 Q3 | -1 Million AUD | 50.09% |
| 2021 FY | -2.44 Million AUD | 25.76% |
| 2021 Q1 | -852 Thousand AUD | 61.37% |
| 2021 Q4 | -1.27 Million AUD | -100.0% |
| 2021 Q3 | -636.05 Thousand AUD | 45.66% |
| 2021 Q2 | -1.17 Million AUD | -37.39% |
| 2020 FY | -3.29 Million AUD | -1316.62% |
| 2020 Q4 | -2.2 Million AUD | -158.86% |
| 2020 Q3 | -852 Thousand AUD | 29.15% |
| 2020 Q2 | -1.2 Million AUD | -100.0% |
| 2020 Q1 | -601.25 Thousand AUD | 0.0% |
| 2019 Q3 | -11.19 Thousand AUD | 0.0% |
| 2019 FY | -232.25 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 59.449% |
| Acrux Limited | -9.83 Million AUD | 78.304% |
| Actinogen Medical Limited | -12.83 Million AUD | 83.382% |
| AnteoTech Limited | -11.72 Million AUD | 81.805% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 62.378% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 70.338% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -46.226% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 89.115% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 51.782% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 53.508% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 30.33% |
| Biome Australia Limited | -1.91 Million AUD | -11.519% |
| Biotron Limited | -5.15 Million AUD | 58.58% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 85.485% |
| BTC Health Limited | 1.05 Million AUD | 302.185% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 82.667% |
| CSL Limited | 5.64 Billion AUD | 100.038% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 95.238% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 104.341% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 75.776% |
| Dimerix Limited | -25.05 Million AUD | 91.486% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 121.959% |
| Hexima Limited | -1 Million AUD | -111.512% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | 25.755% |
| Immuron Limited | -5.8 Million AUD | 63.22% |
| Immutep Limited | -44.93 Million AUD | 95.252% |
| Imugene Limited | -140.93 Million AUD | 98.486% |
| Memphasys Limited | -2.7 Million AUD | 21.094% |
| Nanollose Limited | -1.24 Million AUD | -70.714% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 100.944% |
| Noxopharm Limited | -7.53 Million AUD | 71.684% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -3.747% |
| Nyrada Inc. | -4.56 Million AUD | 53.213% |
| Orthocell Limited | -11.68 Million AUD | 81.734% |
| PharmAust Limited | -6.65 Million AUD | 67.957% |
| Patrys Limited | -3.53 Million AUD | 39.714% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 96.723% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 70.496% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 70.31% |
| PYC Therapeutics Limited | -38.85 Million AUD | 94.509% |
| Race Oncology Limited | -13.38 Million AUD | 84.054% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 95.481% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 90.324% |
| Starpharma Holdings Limited | -15.15 Million AUD | 85.925% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Tissue Repair Ltd | -4.87 Million AUD | 56.242% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 64.07% |